These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28685239)

  • 1. A BioDesign Approach to Obtain High Yields of Biosimilars by Anti-apoptotic Cell Engineering: a Case Study to Increase the Production Yield of Anti-TNF Alpha Producing Recombinant CHO Cells.
    Gulce Iz S; Inevi MA; Metiner PS; Tamis DA; Kisbet N
    Appl Biochem Biotechnol; 2018 Jan; 184(1):303-322. PubMed ID: 28685239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-x(L).
    Majors BS; Betenbaugh MJ; Pederson NE; Chiang GG
    Biotechnol Bioeng; 2008 Oct; 101(3):567-78. PubMed ID: 18727128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced transient recombinant protein production in CHO cells through the co-transfection of the product gene with Bcl-xL.
    Zustiak MP; Jose L; Xie Y; Zhu J; Betenbaugh MJ
    Biotechnol J; 2014 Sep; 9(9):1164-74. PubMed ID: 24604826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
    Figueroa B; Chen S; Oyler GA; Hardwick JM; Betenbaugh MJ
    Biotechnol Bioeng; 2004 Mar; 85(6):589-600. PubMed ID: 14966800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new CHO (Chinese hamster ovary)-derived cell line expressing anti-TNFα monoclonal antibody with biosimilar potential.
    Luchese MD; Lopes Dos Santos M; Garbuio A; Targino RC; Mansueli CP; Tsuruta LR; Quintilio W; Moro AM
    Immunol Res; 2018 Jun; 66(3):392-405. PubMed ID: 29855993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced production of anti-PD1 antibody in CHO cells through transient co-transfection with anti-apoptotic genes Bcl-x
    Zhang X; Han L; Zong H; Ding K; Yuan Y; Bai J; Zhou Y; Zhang B; Zhu J
    Bioprocess Biosyst Eng; 2018 May; 41(5):633-640. PubMed ID: 29368032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures.
    Figueroa B; Sauerwald TM; Oyler GA; Hardwick JM; Betenbaugh MJ
    Metab Eng; 2003 Oct; 5(4):230-45. PubMed ID: 14642351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the integral membrane protein ErbB2 in Chinese hamster ovary cells expressing the anti-apoptotic gene Bcl-xL.
    O'Connor S; Li E; Majors BS; He L; Placone J; Baycin D; Betenbaugh MJ; Hristova K
    Protein Expr Purif; 2009 Sep; 67(1):41-7. PubMed ID: 19376231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
    Chiang GG; Sisk WP
    Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
    Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
    Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment.
    Rajendra Y; Hougland MD; Alam R; Morehead TA; Barnard GC
    Biotechnol Bioeng; 2015 May; 112(5):977-86. PubMed ID: 25502369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different transient gene expression systems for the production of a new humanized anti-HER2 monoclonal antibody (Hersintuzumab).
    Roshani A; Mohammadi M; Bahadori T; Ahmadi Zare H; Judaki MA; Mobini M; Golsaz-Shirazi F; Jeddi-Tehrani M; Amiri MM; Shokri F
    Daru; 2023 Dec; 31(2):221-231. PubMed ID: 37695454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of SIRT6 alleviates apoptosis and enhances cell viability and monoclonal antibody expression in CHO-K1 cells.
    Hashemi N; Tabatabaee SH; Shams F; Rahimpour A; Kazemi B; Rajabibazl M; Ranjbari J
    Mol Biol Rep; 2023 Jul; 50(7):6019-6027. PubMed ID: 37286776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Bcl-x(L) overexpression on lactate metabolism in chinese hamster ovary cells producing antibody.
    Ha TK; Jeon MK; Yu DY; Lee GM
    Biotechnol Prog; 2013; 29(6):1594-8. PubMed ID: 24039207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 27 overexpression in CHO cells modulates apoptosis pathways and delays activation of caspases to improve recombinant monoclonal antibody titre in fed-batch bioreactors.
    Tan JG; Lee YY; Wang T; Yap MG; Tan TW; Ng SK
    Biotechnol J; 2015 May; 10(5):790-800. PubMed ID: 25740626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase recombinant antibody yields through optimizing vector design and production process in CHO cells.
    Yang Y; Li Z; Li Q; Ma K; Lin Y; Feng H; Wang T
    Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):4963-4975. PubMed ID: 35788878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of functional similarity of biosimilar H9P2S from an investigational CHO clone with Adalimumab.
    Gupta K; Desai R; Jawade K; Jagtap DD; Modi D; Jain R; Dandekar P
    3 Biotech; 2022 Nov; 12(11):315. PubMed ID: 36276478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
    Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level protein expression in scalable CHO transient transfection.
    Ye J; Kober V; Tellers M; Naji Z; Salmon P; Markusen JF
    Biotechnol Bioeng; 2009 Jun; 103(3):542-51. PubMed ID: 19199356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.